UK markets open in 3 hours 42 minutes

Biogen Inc. (BIIB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
269.73-11.46 (-4.08%)
At close: 4:00PM EDT
269.50 -0.23 (-0.09%)
After hours: 07:59PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
31/12/2017
Total revenue
11,697,700
13,444,600
14,377,900
13,452,900
12,273,900
Cost of revenue
1,877,500
1,805,200
1,955,400
1,816,300
1,630,000
Gross profit
9,820,200
11,639,400
12,422,500
11,636,600
10,643,900
Operating expenses
Research development
3,966,300
3,990,900
2,280,600
2,597,200
2,253,600
Selling general and administrative
2,611,600
2,504,500
2,374,700
2,106,300
1,935,500
Total operating expenses
7,804,600
7,193,100
5,386,800
5,635,800
5,116,100
Operating income or loss
2,015,600
4,446,300
7,035,700
6,000,800
5,527,800
Interest expense
233,300
222,500
187,400
200,600
250,800
Total other income/expenses net
561,900
781,700
157,600
-13,100
-226,700
Income before tax
2,359,800
5,047,500
7,125,900
5,899,600
5,128,800
Income tax expense
-110,800
992,300
1,158,000
1,425,600
2,458,700
Income from continuing operations
2,491,600
4,060,500
5,888,500
4,474,000
2,670,100
Net income
1,918,100
4,000,600
5,888,500
4,430,700
2,539,100
Net income available to common shareholders
1,918,100
4,000,600
5,888,500
4,430,700
2,539,100
Basic EPS
-
24.86
31.47
21.63
11.94
Diluted EPS
-
24.80
31.42
21.58
11.92
Basic average shares
-
160,900
187,100
204,900
212,600
Diluted average shares
-
161,300
187,400
205,300
213,000
EBITDA
-
5,734,800
7,993,900
7,116,800
6,460,600